Složene optičke halucinacije kod bolesnika sa očuvanim uvidom: četiri slučaja Šarl Boneovog sindroma

  • Vesna Tepšić Ostojić Military Medical Academy, Psychiatric Clinic, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Zagorka Gojković Military Medical Academy, Psychiatric Clinic, Belgrade, Serbia
  • Bratislav Živić Military Medical Academy, Psychiatric Clinic, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Ključne reči: šarl boneov sindrom, dijagnoza, diferencijalna, halucinacije, vid, poremećaji

Sažetak


Uvod. Složene optičke halucinacije sa očuvanim uvidom kod bolesnika sa oštećenjem vida predstavljaju ključni simptom Šarl Boneovog sidroma. Ovaj sindrom je uvršten u jedanaestu reviziju Međunarodne klasifikacije bolesti kao samostalna dijagnoza. Ipak, često se u kliničkoj praksi bolesnicima sa tim sindromom pogrešno dijagnostikuje psihoza ili početna faza demencije, a sindrom retko prijavljuju i bolesnici, zbog straha od postavljanja dijagnoze mentalnog oboljenja. Prikaz bolesnika. Prikazali smo četiri bolesnika starijeg životnog doba, koji su bili upućeni na psihijatrijsku konsultaciju zbog optičkih halucinacija, uz očuvani uvid, a sa oštećenjem vida. Sva četiri bolesnika imala su složene, žive halucinacije u boji, koje su predstavljale realne predmete, ljude, životinje i pejzaže i koje su se ponavljale. Emocionalni odgovor i uticaj na kvalitet života tih bolesnika bio je različit, a psihofarmakoterapija je bila određena u skladu sa kliničkom slikom. Pokazivanje empatije u objašnjavanju porekla simptoma i razuveravanje da se ne radi o psihijatrijskom poremećaju, bili su od velikog značaja kod svih bolesnika, kao i kod njima bliskih osoba. Zaključak. Starenjem populacije povećava se i broj bolesnika koji imaju oštećenje vida i naglašava se značaj multidsciplinarnog pristupa u dijagnostici i terapiji Šarl Boneovog sidroma. Potrebno je povećati svest o kliničkim karakteristikama i terapijskom pristupu kod svih lekara koji su u kontaktu sa starijim bolesnicima i/ili bolesnicima sa oštećenjem vida.

Reference

Hedges TR Jr. Charles Bonnet, his life, and his syndrome. Surv Ophthalmol 2007; 52(1): 111–4.

Vukicevic M, Fitzmaurice K. Butterflies and black lacy pat-terns: the prevalence and characteristics of Charles Bonnet hallucinations in an Australian population. Clin Exp Ophthalmol 2008; 36(7): 659–65.

Jan T, Del Castillo J. Visual hallucinations: Charles Bonnet syndrome. West J Emerg Med 2012; 13(6): 544‒7.

Jones L, Ditzel-Finn L, Enoch J, Moosajee M. An overview of psychological and social factors in Charles Bonnet syn-drome. Ther Adv Ophthalmol 2021; 13: 25158414211034715.

Doeller B, Kratochwil M, Sifari L, Hirnschall N, Findl O. Ben-efit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome. BMJ Open Ophthalmol 2021; 6(1): e000463.

Pang L. Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome. Optom Vis Sci 2016; 93(12): 1466‒78.

World Health Organization (WHO). International Classifica-tion of Diseases, 11th Revision (ICD-11) [Internet]. 2022 [accessed on 2023 July 14]. Available from: https://icd.who.int/browse11/l-m/en

Ffytche DH. Visual hallucinations and the Charles Bonnet syndrome. Curr Psychiatry Rep 2005; 7(3): 168‒79.

Donovan NJ, Blazer D. Social Isolation and Loneliness in Older Adults: Review and Commentary of a National Academies Report. Am J Geriatr Psychiatry 2020; 28(12): 1233‒44.

Le JT, Peprah D, Agrón E, Keenan TD, Clemons TE, Chew EY, et al. Associations between Age-Related Eye Diseases and Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2: Report Number 26. Oph-thalmology 2022; 129(2): 233‒5.

Singh A, Subhi Y, Sørensen TL. Low awareness of the Charles Bonnet syndrome in patients attending a retinal clinic. Dan Med J 2014; 61(2): A4770.

Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347(9004): 794‒7.

Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual halluci-nations in patients with retinal disease. Am J Ophthalmol 2001; 131(5): 590‒8.

Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfu-sion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in pa-tients with Charles Bonnet syndrome. Psychiatry Clin Neurosci 2000; 54(2): 157‒62.

Cox TM, Ffytche DH. Negative outcome Charles Bonnet syndrome. Br J Ophthalmol 2014; 98(9): 1236‒9.

Rojas LC, Gurnani B. Charles Bonnet Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Pub-lishing; 2022 [updated 2022 Dec 6; cited on 2023 Jan]. Available from: https://www.ncbi.nlm.nih.gov/books/NB

K585133/

Doane J, Stults B. Visual hallucinations related to angioten-sin-converting enzyme inhibitor use: case reports and re-view. J Clin Hypertens (Greenwich) 2013; 15(4): 230‒3.

Alao AO, Hanrahan B. Charles Bonnet syndrome: visual hallucination and multiple sclerosis. Int J Psychiatry Med 2003; 33(2): 195‒9.

Holroyd S, Rabins PV. A three-year follow-up study of vis-ual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996; 184(3): 188‒9.

Objavljeno
2023/11/02
Rubrika
Prikaz bolesnika